InterShunt designs and develops a catheter based minimally-invasive procedure to provide relief for millions suffering from heart failure.
InterShunt's investors include Solas BioVentures, gbeta, Accelerate Venture Partners, MedTech Innovator, Arsenal Capital Management.
InterShunt is headquartered in St Louis, United States.
InterShunt designs and develops a catheter based minimally-invasive procedure to provide relief for millions suffering from heart failure.
InterShunt is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InterShunt — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/intershunt. Accessed October 3, 2026.
VCBacked. (2023). InterShunt — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/intershunt
{{cite web |title=InterShunt — Funding & Investors |url=https://www.vcbacked.co/company/intershunt |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated